GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford BioDynamics PLC (STU:LMQ) » Definitions » Forward Dividend Yield %

Oxford BioDynamics (STU:LMQ) Forward Dividend Yield % : 0.00% (As of May. 15, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Oxford BioDynamics Forward Dividend Yield %?

As of today (2025-05-15), the Forward Annual Dividend Yield of Oxford BioDynamics is 0.00%.

As of today (2025-05-15), the Trailing Annual Dividend Yield of Oxford BioDynamics is 0.00%.

STU:LMQ's Forward Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.665
* Ranked among companies with meaningful Forward Dividend Yield % only.

Oxford BioDynamics's Dividends per Share for the six months ended in Sep. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Oxford BioDynamics's Forward Dividend Yield %

For the Diagnostics & Research subindustry, Oxford BioDynamics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's Forward Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Forward Dividend Yield % falls into.


;
;

Oxford BioDynamics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Oxford BioDynamics  (STU:LMQ) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Oxford BioDynamics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
John Smith Drive, 3140 Rowan Place, ARC Oxford, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company engaged in developing and commercializing precision clinical diagnostic tests for life-changing diseases. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The tests are based on the company's proprietary 3D genomic biomarker platform, EpiSwitch which enables screening, evaluation, validation, and monitoring of biomarkers. In addition, the company offers, EpiSwitch Explorer Array Kit for 3D genome profiling. It is also developing new tests in the areas of oncology, neurology, inflammation, hepatology, and animal health. Geographically, it derives key revenue from the United States of America.

Oxford BioDynamics Headlines

No Headlines